323 related articles for article (PubMed ID: 7283656)
1. [Patent ductus arteriosus in premature newborns. Treatment with indomethacin (author's transl)].
Marchal F; Monin P; Vert P; Bianchetti G; Morselli PL
Arch Fr Pediatr; 1981; 38(7):503-8. PubMed ID: 7283656
[TBL] [Abstract][Full Text] [Related]
2. A comparison of oral ibuprofen and intravenous indomethacin for closure of patent ductus arteriosus in preterm infants.
Chotigeat U; Jirapapa K; Layangkool T
J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S563-9. PubMed ID: 14700149
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and clinical efficacy of indomethacin in premature infants with patent ductus arteriosus.
Regazzi MB; Rondanelli R; Vidale E; Chirico G; Rondini G; Chiara A; Piccolo A
Int J Clin Pharmacol Res; 1984; 4(2):109-12. PubMed ID: 6469435
[TBL] [Abstract][Full Text] [Related]
4. A comparison of oral and intravenous indomethacin dispositions in the premature infant with patent ductus arteriosus.
Evans M; Bhat R; Vidyasagar D; Patel M; Hastreiter A
Pediatr Pharmacol (New York); 1981; 1(3):251-8. PubMed ID: 7346745
[TBL] [Abstract][Full Text] [Related]
5. Oral ibuprofen and indomethacin for treatment of patent ductus arteriosus in premature infants: a randomized trial at Ramathibodi Hospital.
Supapannachart S; Limrungsikul A; Khowsathit P
J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1252-8. PubMed ID: 12549803
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness and side effects of an escalating, stepwise approach to indomethacin treatment for symptomatic patent ductus arteriosus in premature infants below 33 weeks of gestation.
Sperandio M; Beedgen B; Feneberg R; Huppertz C; Brüssau J; Pöschl J; Linderkamp O
Pediatrics; 2005 Dec; 116(6):1361-6. PubMed ID: 16322159
[TBL] [Abstract][Full Text] [Related]
7. [Treatment with intravenous indomethacin of symptomatic ductus arteriosus in premature newborn infants].
Valls i Soler A; Benito J; Pastor E; López Heredia I; Santiago M; Cabrera A
An Esp Pediatr; 1987 Aug; 27(2):112-6. PubMed ID: 3662265
[TBL] [Abstract][Full Text] [Related]
8. Indomethacin therapy in premature infants with patent ductus arteriosus--determination of therapeutic plasma levels.
Yeh TF; Achanti B; Patel H; Pildes RS
Dev Pharmacol Ther; 1989; 12(4):169-78. PubMed ID: 2766920
[TBL] [Abstract][Full Text] [Related]
9. Indomethacin treatment for symptomatic patent ductus arteriosus: a double-blind control study.
Yanagi RM; Wilson A; Newfeld EA; Aziz KU; Hunt CE
Pediatrics; 1981 May; 67(5):647-52. PubMed ID: 7019841
[TBL] [Abstract][Full Text] [Related]
10. Oral ibuprofen in early curative closure of patent ductus arteriosus in very premature infants.
Cherif A; Jabnoun S; Khrouf N
Am J Perinatol; 2007 Jun; 24(6):339-45. PubMed ID: 17564958
[TBL] [Abstract][Full Text] [Related]
11. Consequences of delayed surgical closure of patent ductus arteriosus in very premature infants.
Jaillard S; Larrue B; Rakza T; Magnenant E; Warembourg H; Storme L
Ann Thorac Surg; 2006 Jan; 81(1):231-4. PubMed ID: 16368371
[TBL] [Abstract][Full Text] [Related]
12. Pharmacologic closure of patent ductus arteriosus in the premature infant.
Friedman WF; Hirschklau MJ; Printz MP; Pitlick PT; Kirkpatrick SE
N Engl J Med; 1976 Sep; 295(10):526-9. PubMed ID: 820994
[TBL] [Abstract][Full Text] [Related]
13. [Controlled trial of intravenous lyophilized indomethacin in the treatment of persistent ductus arteriosus in premature infants].
Monset-Couchard M; Dias-Mançano D; Murat I; Relier JP
Pediatrie; 1983 Sep; 38(6):365-77. PubMed ID: 6364030
[TBL] [Abstract][Full Text] [Related]
14. Early versus late indomethacin treatment for patent ductus arteriosus in premature infants with respiratory distress syndrome.
Van Overmeire B; Van de Broek H; Van Laer P; Weyler J; Vanhaesebrouck P
J Pediatr; 2001 Feb; 138(2):205-11. PubMed ID: 11174617
[TBL] [Abstract][Full Text] [Related]
15. Orogastric and intravenous indomethacin administration to very premature neonates with patent ductus arteriosus: population pharmacokinetics, absolute bioavailability, and treatment outcome.
Al Za'abi M; Donovan T; Tudehope D; Woodgate P; Collie LA; Charles B
Ther Drug Monit; 2007 Dec; 29(6):807-14. PubMed ID: 18043480
[TBL] [Abstract][Full Text] [Related]
16. [Therapeutic problems with indomethacin in preterm infants with persistent ductus arteriosus].
Seyberth HW; Müller H; Wille L; Plückthun H; Ulmer HE; Wolf D
Monatsschr Kinderheilkd; 1983 Feb; 131(2):71-6. PubMed ID: 6843560
[TBL] [Abstract][Full Text] [Related]
17. Is oral indomethacin effective in treatment of preterm infants with patent ductus arteriosus?
Satar M; Yapicioğlu H; Narli N; Ozbarlas N; Küçükosmanoğlu O; Tutak E
Turk J Pediatr; 2004; 46(2):137-41. PubMed ID: 15214742
[TBL] [Abstract][Full Text] [Related]
18. Indomethacin for patent ductus arteriosus closure. Application of serum concentrations and pharmacodynamics to improve response.
Gal P; Ransom JL; Schall S; Weaver RL; Bird A; Brown Y
J Perinatol; 1990 Mar; 10(1):20-6. PubMed ID: 2313390
[TBL] [Abstract][Full Text] [Related]
19. Closure of the ductus arteriosus in premature infants by inhibition of prostaglandin synthesis.
Heymann MA; Rudolph AM; Silverman NH
N Engl J Med; 1976 Sep; 295(10):530-3. PubMed ID: 950959
[TBL] [Abstract][Full Text] [Related]
20. Combined treatment with a nonselective nitric oxide synthase inhibitor (l-NMMA) and indomethacin increases ductus constriction in extremely premature newborns.
Keller RL; Tacy TA; Fields S; Ofenstein JP; Aranda JV; Clyman RI
Pediatr Res; 2005 Dec; 58(6):1216-21. PubMed ID: 16306196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
